Salarius Appoints Non Executive Director

RNS Number : 6823W
Tekcapital plc
24 December 2021
 


 

 

24 December 2021

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

 

Portfolio Company Update: Salarius, Ltd. ("Salarius")

Appointment of Dan Emery as a Non-Executive Director of MicroSalt Inc.

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology that can improve people's lives, is pleased to announce that Salarius' U.S. subsidiary MicroSalt Inc  (MicroSalt) has appointed Dan Emery as a member of its board of directors.

 

Dan has more than 25 years of experience in the food industry, including 15 years as vice president of sales and marketing at Pilgrim's Pride, during which time sales grew from US$970 million to US$8.5 billion, with a balance between retail and food service. Previously Dan served as CEO/President of GreenStar Cooperative, where he led a business resurgence in the company's three divisions: gourmet food distribution, agricultural products, and turf products. Currently Dan is President of WPCI a national provider of third-party administrator of employment services including, drug testing, DOT compliance, and background checks. 

 

"Having developed and launched numerous, highly successful, food products, I feel strongly that MicroSalt's ability to deliver the equivalent flavour of snacks with 50% less sodium presents a significant global opportunity for the Company and its potential customers," said Dan Emery, Director of MicroSalt®.

 

About Salarius Ltd. and MicroSalt, Inc.

Salarius, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving peoples' lives by providing the best low-sodium salt, based on the mechanical transformation of the salt particle itself. MicroSalt, Inc., Salarius' U.S. operating subsidiary, aims to revolutionize the food industry with its patented better-for-you salt, that delivers the full-flavour experience of salt with roughly half the sodium. MicroSalt® is all-natural, non-GMO, and Kosher.

 

Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavor consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc.

 

To learn more about MicroSalt please visit https://Salarius.co /.  

To learn more about SaltMe! snacks please visit   https://saltme.com/ .

 

Tekcapital owns 97.2% of the share capital of Salarius Ltd. and approximately 87% of the share capital of MicroSalt Inc., its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com .

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc  


Via Flagstaff IR

Clifford M. Gross, Ph.D. 






SP Angel  Corporate Finance LLP  (Nominated Adviser and Broker)


+44 (0) 20 3470 0470  

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 



 

Flagstaff Strategic and Investor Communications     +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon 

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Salarius that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Salarius' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Salarius or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Salarius nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFFRFELVFIL

Companies

Tekcapital (TEK)
UK 100

Latest directors dealings